The Net Margin of Guizhou Sanli Pharmaceutical Co Ltd (603439.SS) is 2.72%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2025-12-31 | 2.72% |
| 2024-12-31 | 12.78% |
| 2023-12-31 | 17.90% |
| 2022-12-31 | 16.76% |
| 2021-12-31 | 16.22% |
| 2020-12-31 | 14.92% |
| 2019-12-31 | 15.06% |
| 2018-12-31 | 15.30% |
| 2017-12-31 | 13.72% |
| 2016-12-31 | 14.55% |